Stay updated on FG-4592 and Rosiglitazone Interaction Clinical Trial
Sign up to get notified when there's something new on the FG-4592 and Rosiglitazone Interaction Clinical Trial page.

Latest updates to the FG-4592 and Rosiglitazone Interaction Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.6.2 was added and the previous Revision: v3.6.0 was removed, updating the page's version label.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedAdded recruitment status 'No longer looking for participants' and introduced new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). The change also adjusts the Intervention/Treatment heading formatting and includes the site revision note Revision: v3.6.0.SummaryDifference1%

- Check24 days agoChange DetectedAdds a new revision label Revision: v3.5.5, replacing the previous v3.5.4, indicating an update to the page's revision history. The update does not modify study details or displayed content.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page shows a new revision label, v3.5.4, replacing the previous v3.5.3. This indicates a small backend or interface update without affecting the study details presented.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page footer/site revision label was updated from v3.5.2 to v3.5.3, reflecting a maintenance/UI version change rather than any change to the trial information.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This appears to be a metadata/maintenance change and does not affect study details.SummaryDifference0.1%

Stay in the know with updates to FG-4592 and Rosiglitazone Interaction Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FG-4592 and Rosiglitazone Interaction Clinical Trial page.